AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17386350
Drug: telmisartan 160
RxNorm normalized name: Telmisartan
DrugBank: Telmisartan (DB00966)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: telmisartan 160 mg/amlodipine 2.5 mg daily
Trial: 17386350
Drug: amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: amlodipine 5 mg/telmisartan 40 mg daily
Trial: 17386350
Drug: amlodipine 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: amlodipine 7.5 mg/telmisartan 40 mg daily
Trial: 17386350
Drug: amlodipine 10
RxNorm normalized name: amlodipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: amlodipine 10 mg/telmisartan 40 mg daily
Trial: 29974571
Drug: Self-administered misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered misoprostol (S-Mis)
Trial: 29974571
Drug: Hospital-administered misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hospital-administered misoprostol (H-Mis)
Trial: 28923084
Drug: TG4010 with
RxNorm normalized name: TG4010
DrugBank: TG4010 (DB06584)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TG4010 with standard chemotherapy
Trial: 26362774
Drug: 10mg oral
RxNorm normalized name: OPIPZA 10mg Oral Film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10mg oral dose of THCv
Trial: 23220014
Drug: Hemoglobin threshold
RxNorm normalized name: HEMOGLOBIN
DrugBank: Hemoglobin (DB04945)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hemoglobin threshold of 120 g/L (experimental arm)
Trial: 23220014
Drug: Hemoglobin threshold
RxNorm normalized name: HEMOGLOBIN
DrugBank: Hemoglobin (DB04945)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hemoglobin threshold of 70 g/L (control arm)
Trial: 18294232
Drug: Immediately Loaded
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediately Loaded (IL) implants
Trial: 18294232
Drug: Conventionally Loaded
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventionally Loaded (CL) implants
Trial: 10984013
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg sodium valproate
Trial: 10984013
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg sodium valproate
Trial: 10984013
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg sodium valproate
Trial: 10984013
Drug: 100 mg,
RxNorm normalized name: CoQmax Omega 100 mg, 500 mg-100 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg, 150 mg, and 300 mg sodium valproate
Trial: 8105943
Drug: 2.5 mEq/L
RxNorm normalized name: bicarb dialy soln 11 without K calcium (2.5 mEq/L)-magnesium (1.5 mEq/L) HEMODIALYS SOLUTION, NON-ORAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mEq/L calcium dialysate with oral calcitriol (median dose 0.25 microgram/day)
Trial: 8105943
Drug: 3.5 mEq/L
RxNorm normalized name: bicarb dialy soln 7-no pot,dex calcium (3.5 mEq/L)-magnesium (1 mEq/L) HEMODIALYS SOLUTION, NON-ORAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.5 mEq/L calcium dialysate without calcitriol
Trial: 8105943
Drug: 2.5 mEq/L
RxNorm normalized name: bicarb dialy soln 11 without K calcium (2.5 mEq/L)-magnesium (1.5 mEq/L) HEMODIALYS SOLUTION, NON-ORAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mEq/L calcium dialysate with oral calcitriol
Trial: 21556830
Drug: Lactobacillus casei
RxNorm normalized name: Lactobacillus Casei
DrugBank: Lactobacillus casei (DB16541)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus casei treatment for 3 months
Trial: 30268262
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no probiotic treatment)
Trial: 19236785
Drug: supporting treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: supporting treatment
Trial: 18001447
Drug: Intramuscular methylergometrine
RxNorm normalized name: methylergometrine
DrugBank: Methylergometrine (DB00353)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular methylergometrine
Trial: 15021279
Drug: Buprenorphine-soaked absorbable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine-soaked absorbable gelatin sponge (0.3 mg buprenorphine diluted to 5 mL with normal saline)
Trial: 15021279
Drug: Absorbable gelatin
RxNorm normalized name: Absorbable gelatin film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Absorbable gelatin sponge soaked with 5 mL normal saline (control group)
Trial: 12492609
Drug: Intravenous urotensin
RxNorm normalized name: neurotensin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous urotensin II infusion at 300 pmol min‐1
Trial: 12492609
Drug: Intravenous urotensin
RxNorm normalized name: neurotensin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous urotensin II infusion
Trial: 30089762
Drug: Del Nido
RxNorm normalized name: Del Nido Cardioplegia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Del Nido solution (DNS)
Trial: 19661687
Drug: 15 ml
RxNorm normalized name: ethanol 0.15 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 ml of vinegar (750 mg AcOH)
Trial: 19661687
Drug: 30 ml
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 ml of vinegar (1,500 mg AcOH)
Trial: 19661687
Drug: 0 ml
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 ml of vinegar (0 mg AcOH, placebo)
Trial: 11888224
Drug: Venlafaxine (18.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine (18.75 mg daily, increased by one tablet at 1 week intervals)
Trial: 9863332
Drug: Endocervical application
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocervical application of 0.5 mg Dinoprostone (Group I)
Trial: 9863332
Drug: Intravenous application
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous application of Syntocinon (Group II)
Trial: 7675391
Drug: Heparin (anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (anticoagulant of choice)
Trial: 2116057
Drug: Thyrotropin-releasing hormone
RxNorm normalized name: thyrotropin-releasing hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyrotropin-releasing hormone (200 micrograms, as an i.v. bolus)
Trial: 146331
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus heparin
Trial: 28004188
Drug: Paracetamol (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (15 mg/kg/6 h IV infusion for 3 days)
Trial: 28004188
Drug: Ibuprofen (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (10 mg/kg IV infusion followed by 5 mg/kg/day for 2 days)
Trial: 28004188
Drug: Indomethacin (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (0.2 mg/kg/12 h IV infusion for three doses)
Trial: 22018631
Drug: Letrozole monotherapy
RxNorm normalized name: Letrozole
DrugBank: Letrozole (DB01006)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Letrozole monotherapy for 5 years
Trial: 22018631
Drug: Tamoxifen monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen monotherapy for 5 years
Trial: 19886855
Drug: Irbesartan/HCTZ 150/12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan/HCTZ 150/12.5 mg to 300/25 mg
Trial: 9768826
Drug: Dexrazoxane (DEX)
RxNorm normalized name: Dexrazoxane
DrugBank: Dexrazoxane (DB00380)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dexrazoxane (DEX) administered 30 minutes before daunorubicin (DNR) 45 mg/m2 or mitoxantrone (MTX) 10 mg/m2, in doses 8-13 times higher for DNR or 30-60 times higher for MTX, with a treatment cycle including 10 high doses (2,000 mg/m2/12 hr) of cytosine arabinoside plus two doses of DNR or MTX on days 4 and 5.
Trial: 9768826
Drug: Dexrazoxane (DEX)
RxNorm normalized name: Dexrazoxane
DrugBank: Dexrazoxane (DB00380)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dexrazoxane (DEX) as a cardioprotective agent during chemotherapy.
Trial: 9768826
Drug: Delayed administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Delayed administration of DEX after cumulative doses of DNR 500 mg/m2.
Trial: 9768826
Drug: Chemotherapy regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy regimen including DEX, DNR, MTX, and cytosine arabinoside.
Trial: 408860
Drug: L-tryptophan treatment
RxNorm normalized name: L-TRYPTOPHAN
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-tryptophan treatment
Trial: 30901920
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg nicotine of TC (3TC)
Trial: 30901920
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg nicotine of EC (3EC)
Trial: 30901920
Drug: Control 0
RxNorm normalized name: Mane 'N Tail Daily Control 0.5 % Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control 0 mg nicotine of EC (C)
Trial: 22301466
Drug: 24-week pegylated
RxNorm normalized name: Pegylated rfviii
DrugBank: PEGylated Recombinant Factor VIII (DB16093)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-week pegylated interferon plus ribavirin therapy
Trial: 16763372
Drug: Each 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Each 5 mumol/l increment in homocysteine levels
Trial: 16303792
Drug: Docetaxel (66
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (66 mg/m² Day 1)
Trial: 16303792
Drug: Docetaxel (33
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (33 mg/m² Days 1 and 8)
Trial: 16303792
Drug: Arm A
RxNorm normalized name: Warm antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arm A (66 mg/m² Day 1)
Trial: 16303792
Drug: Arm B
RxNorm normalized name: arm brace
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arm B (33 mg/m² Days 1 and 8)
Trial: 16303792
Drug: Response to
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Response to front-line chemotherapy
Trial: 10155119
Drug: Perfusion angioplasty
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perfusion angioplasty as a primary treatment strategy
Trial: 2288830
Drug: 50 ml
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 ml cream (20 g fat) preload with placebo
Trial: 2288830
Drug: 50 ml
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 ml cream (20 g fat) preload with 10 mg cisapride
Trial: 2288830
Drug: 50 ml
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 ml water preload with placebo
Trial: 27764906
Drug: Docetaxel 75
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 75 mg/m2 IV on D1 (D)
Trial: 27764906
Drug: Docetaxel 60
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 60 mg/m2 IV plus cisplatin 60 mg/m² IV on D1 (DC)
Trial: 27764906
Drug: Docetaxel 60
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 60 mg/m2 IV D1 plus oral S-1 30 mg/m2 twice a day on D1-14 (DS)
Trial: 27488051
Drug: L-citrulline and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-citrulline and metformin therapy for 26 weeks
Trial: 27488051
Drug: L-citrulline and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-citrulline and metformin therapy
Trial: 17442681
Drug: Acetaminophen (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (1000 mg) + Caffeine (130 mg)
Trial: 17442681
Drug: Caffeine (130
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (130 mg)
Trial: 11817529
Drug: Heparin-coated (HC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-coated (HC) VVBP equipment
Trial: 9585294
Drug: Lornoxicam (Xefo;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lornoxicam (Xefo; administered i.v. via PCA for up to 24 h)
Trial: 9585294
Drug: Morphine (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (administered i.v. via PCA for up to 24 h)
Trial: 30274699
Drug: Radiofrequency-induced thermo-chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiofrequency-induced thermo-chemotherapy effect (RITE) with 40mg mitomycin-C at 42±2°C for 60 minutes
Trial: 30274699
Drug: Radiofrequency-induced thermo-chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiofrequency-induced thermo-chemotherapy effect (RITE)
Trial: 30274699
Drug: Control (institutional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (institutional standard second-line therapy)
Trial: 26970266
Drug: Armodafinil (150-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Armodafinil (150-200 mg/day)
Trial: 18465241
Drug: Ingesting 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ingesting 500 ml of polyethylene glycol (PEG) starting 30 min after swallowing the capsule
Trial: 18465241
Drug: No preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No preparation (control group A)
Trial: 16371776
Drug: Topical cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cyclosporine A 0.05% (tCsA)
Trial: 9004052
Drug: Doxepin (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxepin (mean daily dosage at 6 weeks 169 +/- 42 mg)
Trial: 9004052
Drug: Fluoxetine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (mean daily dosage at 6 weeks 37 +/- 18 mg)
Trial: 8285374
Drug: Felodipine 10
RxNorm normalized name: felodipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine 10 mg (plain tablet)
Trial: 3100877
Drug: Beclomethasone nasal
RxNorm normalized name: beclomethasone nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone nasal solution
Trial: 30636826
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg melatonin tablets 45 min before sleep for 3 days after surgery
Trial: 22697189
Drug: Aripiprazole-IM-depot (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole-IM-depot (400 mg every 4 weeks, with coadministration of oral aripiprazole for the first 2 weeks)
Trial: 17324600
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human growth hormone (rhGH) 0.058 IU/kg/day for 6 days
Trial: 16246996
Drug: Nortriptyline (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nortriptyline (75 mg once daily)
Trial: 11893367
Drug: Antiresorptive drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiresorptive drugs (e.g., alendronate)
Trial: 11893367
Drug: Antiresorptive treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiresorptive treatments (general)
Trial: 8154632
Drug: Albuterol via
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol via metered dose inhaler (MDI)
Trial: 8154632
Drug: Albuterol via
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol via AeroChamber
Trial: 8154632
Drug: Albuterol via
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol via OptiHaler
Trial: 8154632
Drug: Placebo via
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo via metered dose inhaler (MDI)
Trial: 22256669
Drug: Vertical/horizontal combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vertical/horizontal combination grab bar configuration
Trial: 22256669
Drug: L-shaped bar
RxNorm normalized name: L-377202
DrugBank: L-377202 (DB19022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-shaped bar configuration
Trial: 22256669
Drug: Vertical/angled combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vertical/angled combination grab bar configuration
Trial: 21429720
Drug: 15-g soy
RxNorm normalized name: SOY ACID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15-g soy protein and 100-mg isoflavone
Trial: 21429720
Drug: 15-g milk
RxNorm normalized name: magnesium hydroxide
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 15-g milk protein and 100-mg isoflavone
Trial: 21429720
Drug: 15-g milk
RxNorm normalized name: magnesium hydroxide
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 15-g milk protein (placebo group)
Trial: 18462730
Drug: Myo-inositol combined
RxNorm normalized name: myo-inositol
DrugBank: Inositol (DB13178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Myo-inositol combined with folic acid (Inofolic) 2 g twice a day
Trial: 17552953
Drug: 1-day ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 1-day ciprofloxacin XR 1000 mg
Trial: 17552953
Drug: 3-day ciprofloxacin
RxNorm normalized name: ciprofloxacin 3 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-day ciprofloxacin XR 1000 mg
Trial: 7835330
Drug: FE-27 (27
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FE-27 (27 mg iron x day‐1)
Trial: 7835330
Drug: FE-9 (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FE-9 (9 mg iron x day‐1)
Trial: 31841023
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) for 8 weeks
Trial: 29063521
Drug: Mindfulness-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-based cognitive therapy (MBCT) for 8 weeks
Trial: 31841023
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) and Mindfulness-based cognitive therapy (MBCT)
Trial: 28254462
Drug: ASP3652 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASP3652 25 mg twice daily
Trial: 28254462
Drug: ASP3652 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASP3652 75 mg, 150 mg, or 300 mg once daily
Trial: 28254462
Drug: ASP3652 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASP3652 (all doses)
Trial: 21547897
Drug: Oral cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cyclophosphamide (CYC) treatment for 12 months
Trial: 18001798
Drug: Intravesical pentosan
RxNorm normalized name: Pentosan polysulfate
DrugBank: Pentosan polysulfate (DB00686)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravesical pentosan polysulfate sodium plus oral pentosan polysulfate sodium
Trial: 18001798
Drug: Intravesical placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical placebo plus oral pentosan polysulfate sodium
Trial: 14602435
Drug: Parent-initiated oral
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parent-initiated oral prednisolone (20 mg once daily for 5 days)
Trial: 27055257
Drug: Medical device
RxNorm normalized name: EndeavoRx Digital Medical Device
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical device (MD; a capsule whose main component is a cross‐linked protein)
Trial: 27055257
Drug: Ciprofloxacin 500
RxNorm normalized name: ciprofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 500 mg/day and 1 capsule/day
Trial: 24665980
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Transmetil 1000 mg/d or Essentiale 1368 mg/d)
Trial: 17519049
Drug: lornoxicam 16
RxNorm normalized name: Lornoxicam 16 mg prolonged-release oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lornoxicam 16 mg
Trial: 17519049
Drug: tenoxicam 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tenoxicam 40 mg
Trial: 15226623
Drug: Ticlopidine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine (200 mg/day) plus aspirin (81 mg/day)
Trial: 15226623
Drug: Cilostazol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilostazol (200 mg/day) plus aspirin (81 mg/day)
Trial: 23555538
Drug: Ticlopidine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine (200 mg/day)
Trial: 7925336
Drug: Pethidine 1
RxNorm normalized name: Pethidine
DrugBank: Meperidine (DB00454)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pethidine 1 mg kg‐1 and atropine 0.02 mg kg‐1 intramuscularly 90 min prior to surgery (n = 10)
Trial: 7925336
Drug: Midazolam 0.5
RxNorm normalized name: midazolam 0.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.5 mg kg‐1 and atropine 0.02 mg kg‐1 orally, 120 min before surgery (n = 10)
Trial: 2697552
Drug: Lactitol (19
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactitol (19 g anhydrous)
Trial: 2697552
Drug: Lactulose (19
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactulose (19 g)
Trial: 2697552
Drug: Other test
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other test compounds (Sorbitol 10 g, Mannitol 10 g, Maltitol 19 g, Palatinit 19 g anhydrous)
Trial: 28183583
Drug: Patients on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients on antidepressants (n=76)
Trial: 23547849
Drug: Tocilizumab 162
RxNorm normalized name: TOCILIZUMAB 162MG/0.9ML AUTOINJECTOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab 162 mg
Trial: 23547849
Drug: Tocilizumab 162
RxNorm normalized name: TOCILIZUMAB 162MG/0.9ML AUTOINJECTOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab 162 mg with rHuPH20